Research Articles | Page 79 | Aplastic Anemia and MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Eculizumab: a guide to its use in paroxysmal nocturnal hemoglobinuria Apr 2012 BioDrugs paroxysmal nocturnal hemoglobinuria (PNH)
Alternative donor HSCT in refractory acquired aplastic anemia - Prevention of graft rejection and graft versus host disease by immunoablative conditioning and graft manipulation Mar 2012 Pediatr Transplant aplastic anemia
Asymptomatic cerebral bleeds in patients with aplastic anemia. Mar 2012 Ann Hematol aplastic anemia
Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation Mar 2012 Blood Cancer J paroxysmal nocturnal hemoglobinuria (PNH)
Prognostic relevance of cytogenetic systems in myelodysplastic syndromes. Mar 2012 Leuk Lymphoma myelodysplastic syndromes (MDS)
Rabbit-antithymocyte globulin combined with cyclosporin A as a first-line therapy: improved, effective, and safe for children with acquired severe aplastic anemia. Mar 2012 J Cancer Res Clin Oncol aplastic anemia
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge Mar 2012 J Clin Oncol myelodysplastic syndromes (MDS)
Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium study. Mar 2012 Leuk Res paroxysmal nocturnal hemoglobinuria (PNH)
HLA-Matched Sibling Transplantation for Severe Aplastic Anemia: Impact of HLA DR15 Antigen Status on Engraftment, Graft-versus-Host Disease, and Overall Survival. Feb 2012 Biol Blood Marrow Transplant aplastic anemia
5-Azacitidine efficacy and safety in patients aged >65 years with myelodysplastic syndromes outside clinical trials Feb 2012 Leuk Lymphoma myelodysplastic syndromes (MDS)